Business
PharmaCielo Doubles Its Portfolio of Proprietary Cannabis Strains Approved for Colombia's Cultivar Registration
PharmaCielo Doubles Its Portfolio of Proprietary Cannabis Strains Approved for Colombia's ...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"\n\n\n\nPharmaCielo Doubles Its Portfolio of Proprietary Cannabis Strains Approved for Colombia's Cultivar Registration\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO and RIONEGRO, COLOMBIA, March 29, 2019\n\n\n\nAdds 10 new THC-dominant strains to previously approved group, including unique 1:1 ratio strain Company holds the largest and most diversified portfolio of cultivar-registered strains in Colombia PharmaCielo has 10 additional strain applications awaiting approval TORONTO and RIONEGRO, COLOMBIA, March 29, 2019 /CNW/ - PharmaCielo Ltd. (\"PharmaCielo\" or the \"Company\") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that its Colombian subsidiary has received from the national cultivar registry approval for the listing of a further 10 strains, each of which has a prominent tetrahydrocannabinol (THC) profile.\nThe additional registration of the new strains to the national cultivar registry, including a unique 1:1 THC to CBD ratio strain, doubles the number of approved strains PharmaCielo holds in the registry, making it the largest holder of approved strains in Colombia. It also paves the way for the commercial registration, production and sale of the 20 unique strains.\n\"The approval and registration of a second set of strains with the national cultivar registry is another important step towards PharmaCielo's goal of becoming a leading global supplier of premium medicinal-grade cannabis oils,\" said Federico Cock-Correa, president and CEO of PharmaCielo Colombia Holdings S.A.S. \"The range of the strains now available at our disposal for commercial production is an important advantage that sets the company apart in both the Colombian and global marketplaces.\"\nThe announcement comes on the heels of another set of strains PharmaCielo recently registered with the national cultivar registry, including a special CBD strain with a unique 20:1 ratio profile. As both the World Health Organization and many countries ar...